European Archives - Page 103 of 1096 - European Medical Journal

Improving Anaphylaxis Diagnosis with Trigger-Specific Findings

Trigger-specific patterns in anaphylaxis improve diagnosis and treatment, reducing delays in life-saving emergency care.

Blood Test Ratios May Predict Mortality in Patients Requiring Hemodialysis

Neutrophil-to-lymphocyte ratio predicts early mortality in older dialysis patients, offering insights for personalised treatment planning.

Illustration of a heart with a monitor

Heart failure drug market to reach $33.7bn by 2032

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe and Japan.

Study Reveals How Type 2 Diabetes Increases Cardiovascular Risks

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

Bimekizumab Offers Breakthrough Relief for Axial Spondyloarthritis

Bimekizumab reduces pain, stiffness, and fatigue in axial spondyloarthritis, offering a transformative option for managing this chronic condition.

Faster, Accurate Endometriosis Diagnosis with New Biomarker Panel

A novel biomarker panel shows promise for non-invasive endometriosis diagnosis, offering faster, more accurate detection.

New Insights into Genomic Biomarkers for Pancreatic Cancer

A study examining over 2,300 patients has unveiled promising new genomic biomarkers that could improve prognosis and treatment strategies for pancreatic ductal adenocarcinoma…

Advanced Imaging Reveals Prostate Cancer More Extensive Than Previously Thought

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests.

ACG Updates Guidelines For Eosinophilic Oesophagitis Management

The latest clinical guidelines from the American College of Gastroenterology (ACG) aim to improve the diagnosis and treatment of eosinophilic oesophagitis.

Can Online Cognitive Behavioural Therapy Improve Atopic Dermatitis?

Self-guided online CBT is noninferior to clinician-guided CBT for atopic dermatitis, offering effective and resource-efficient treatment.